» Articles » PMID: 31371707

Production of Seedable Amyloid-β Peptides in Model of Prion Diseases Upon PrP-induced PDK1 Overactivation

Overview
Journal Nat Commun
Specialty Biology
Date 2019 Aug 3
PMID 31371707
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

The presence of amyloid beta (Aβ) plaques in the brain of some individuals with Creutzfeldt-Jakob or Gertsmann-Straussler-Scheinker diseases suggests that pathogenic prions (PrP) would have stimulated the production and deposition of Aβ peptides. We here show in prion-infected neurons and mice that deregulation of the PDK1-TACE α-secretase pathway reduces the Amyloid Precursor Protein (APP) α-cleavage in favor of APP β-processing, leading to Aβ40/42 accumulation. Aβ predominates as monomers, but is also found as trimers and tetramers. Prion-induced Aβ peptides do not affect prion replication and infectivity, but display seedable properties as they can deposit in the mouse brain only when seeds of Aβ trimers are co-transmitted with PrP. Importantly, brain Aβ deposition accelerates death of prion-infected mice. Our data stress that PrP, through deregulation of the PDK1-TACE-APP pathway, provokes the accumulation of Aβ, a prerequisite for the onset of an Aβ seeds-induced Aβ pathology within a prion-infectious context.

Citing Articles

Post-translational modifications in prion diseases.

Bizingre C, Bianchi C, Baudry A, Alleaume-Butaux A, Schneider B, Pietri M Front Mol Neurosci. 2024; 17:1405415.

PMID: 39011540 PMC: 11247024. DOI: 10.3389/fnmol.2024.1405415.


Combination of structure-based virtual screening, molecular docking and molecular dynamics approaches for the discovery of anti-prion fibril flavonoids.

Jheng C, Lee C Front Mol Biosci. 2023; 9:1088733.

PMID: 36685276 PMC: 9849400. DOI: 10.3389/fmolb.2022.1088733.


Titanium dioxide and carbon black nanoparticles disrupt neuronal homeostasis via excessive activation of cellular prion protein signaling.

Ribeiro L, Pietri M, Ardila-Osorio H, Baudry A, Boudet-Devaud F, Bizingre C Part Fibre Toxicol. 2022; 19(1):48.

PMID: 35840975 PMC: 9284759. DOI: 10.1186/s12989-022-00490-x.


Reducing PDK1/Akt Activity: An Effective Therapeutic Target in the Treatment of Alzheimer's Disease.

Yang S, Du Y, Zhao X, Wu C, Yu P Cells. 2022; 11(11).

PMID: 35681431 PMC: 9179555. DOI: 10.3390/cells11111735.


A PDK-1 allosteric agonist neutralizes insulin signaling derangements and beta-amyloid toxicity in neuronal cells and in vitro.

Querfurth H, Marshall J, Parang K, Rioult-Pedotti M, Tiwari R, Kwon B PLoS One. 2022; 17(1):e0261696.

PMID: 35061720 PMC: 8782417. DOI: 10.1371/journal.pone.0261696.


References
1.
Calleja V, Laguerre M, de Las Heras-Martinez G, Parker P, Requejo-Isidro J, Larijani B . Acute regulation of PDK1 by a complex interplay of molecular switches. Biochem Soc Trans. 2014; 42(5):1435-40. DOI: 10.1042/BST20140222. View

2.
Hainfellner J, Wanschitz J, Jellinger K, Liberski P, Gullotta F, Budka H . Coexistence of Alzheimer-type neuropathology in Creutzfeldt-Jakob disease. Acta Neuropathol. 1998; 96(2):116-22. DOI: 10.1007/s004010050870. View

3.
Ghetti B, Piccardo P, Spillantini M, Ichimiya Y, Porro M, Perini F . Vascular variant of prion protein cerebral amyloidosis with tau-positive neurofibrillary tangles: the phenotype of the stop codon 145 mutation in PRNP. Proc Natl Acad Sci U S A. 1996; 93(2):744-8. PMC: 40125. DOI: 10.1073/pnas.93.2.744. View

4.
Senechal Y, Kelly P, Cryan J, Natt F, Dev K . Amyloid precursor protein knockdown by siRNA impairs spontaneous alternation in adult mice. J Neurochem. 2007; 102(6):1928-1940. DOI: 10.1111/j.1471-4159.2007.04672.x. View

5.
Jaunmuktane Z, Mead S, Ellis M, Wadsworth J, Nicoll A, Kenny J . Evidence for human transmission of amyloid-β pathology and cerebral amyloid angiopathy. Nature. 2015; 525(7568):247-50. DOI: 10.1038/nature15369. View